Jin David insider trades
Jin David has filed 16 Form 4s with the SEC that we hold, for Fortress Biotech, Inc. (FBIO) (Chief Financial Officer), Avenue Therapeutics, INC. (ATXI) (Interim PFO and COO) and Mustang Bio, INC. (MBIO) (Director). Across all of them we count 4 purchases worth $37.0K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($237) and 0 sales ($0). The largest single trade was a purchase of 35,928 shares of Fortress Biotech, Inc. worth $30.2K, dated 2023-02-10. The first filing on our record is dated 2022-10-28 and the latest 2026-10-01.
Fortress Biotech, Inc. (FBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-30 | P, purchase reported on Form 4 | 5,000 | $2.8K | 2022-12-02 |
| 2023-02-10 | P, purchase reported on Form 4 | 35,928 | $30.2K | 2023-02-14 |
| 2024-07-10 | P, purchase reported on Form 4 | 500 | $3.8K | 2024-07-12 |
Avenue Therapeutics, INC. (ATXI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Mustang Bio, INC. (MBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-30 | P, purchase reported on Form 4 | 247 | $237 | 2025-12-30 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1930732) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms